Decreased Incidence of Cytomegalovirus Infection in Thymoglobulin-Treated Transplant Patients with 6 Months of Valganciclovir Prophylaxis
Authors:
Open Access
- 1 January 2004
- journal article
- website
- Published by Elsevier in American Journal of Transplantation
- Vol. 4 (1) , 148-149
Abstract
No abstract availableThis publication has 3 references indexed in Scilit:
- Cytomegalovirus Disease in High-Risk Transplant Recipients Despite Ganciclovir or Valganciclovir ProphylaxisAmerican Journal of Transplantation, 2003
- Pharmacokinetics of valganciclovir and ganciclovir in renal impairmentClinical Pharmacology & Therapeutics, 2002
- Cytomegalovirus in Renal TransplantationJournal of the American Society of Nephrology, 2001